99% Pure / Internationally Manufactured / Independently Laboratory Tested in the USA / Multidose
ARA-290 is a synthetic peptide derived from erythropoietin (EPO), engineered to selectively activate the innate repair receptor (IRR) without stimulating erythropoiesis (red blood cell production). This selective signaling profile allows for targeted investigation into tissue repair and inflammation modulation pathways while avoiding broader hematopoietic effects.
ARA-290 is studied for its ability to activate repair-specific signaling pathways at the cellular level. Research suggests it influences:
This targeted mechanism provides a unique framework for studying repair focused biological responses without activating unrelated systems.
ARA-290 is widely studied for its role in enhancing tissue repair processes. In controlled research models, it has demonstrated relevance in:
A defining feature of ARA-290 is its ability to modulate inflammatory responses without broadly suppressing immune function. Research has explored its role in:
ARA-290 is frequently studied for its influence on neurological pathways and nerve-related signaling. Research suggests it may:
Beyond isolated pathways, ARA-290 is studied for its broader impact on cellular resilience. Research models have examined its ability to:
One of the key advantages of ARA-290 is its selective activation of the innate repair receptor without stimulating erythropoiesis. This allows researchers to:
For research purposes only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
Scroll for More >>
International Product
A synthetic peptide fragment provided for research use, manufactured with standardized processes and supported by batch-level verification.
$80.00
IMPORTANT: Research Use Only
By entering this website, you acknowledge that all products sold by Newbridge Peptides are intended strictly for research purposes only. They are not for human or animal consumption, medical use, or any use not permitted by applicable law.